| Bioactivity | ANKRD22-IN-1 is a potent inhibitor of ANKRD22. ANKRD22-IN-1 promotes the expansion of gastrointestinal mucosal epithelial stem cells and indirectly activates the Wnt classical pathway, which helps the recovery of damaged gastrointestinal mucosal tissues in the body (extracted from patent CN111205231B)[1]. |
| Name | ANKRD22-IN-1 |
| CAS | 1107710-62-2 |
| Formula | C22H30N4O4 |
| Molar Mass | 414.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yongquan Zhu, et al. Lead compounds as ankrd22 inhibitors and their applications. Patent CN111205231B. |
ANKRD22-IN-1
CAS: 1107710-62-2 F: C22H30N4O4 W: 414.50
ANKRD22-IN-1 is a potent inhibitor of ANKRD22. ANKRD22-IN-1 promotes the expansion of gastrointestinal mucosal epithelia
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.